ATE399778T1 - Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon - Google Patents

Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon

Info

Publication number
ATE399778T1
ATE399778T1 AT02714415T AT02714415T ATE399778T1 AT E399778 T1 ATE399778 T1 AT E399778T1 AT 02714415 T AT02714415 T AT 02714415T AT 02714415 T AT02714415 T AT 02714415T AT E399778 T1 ATE399778 T1 AT E399778T1
Authority
AT
Austria
Prior art keywords
glucopyranoside
isolation
pharmaceutical composition
hydroxybenzylbenzofuran
beta
Prior art date
Application number
AT02714415T
Other languages
English (en)
Inventor
Rakesh Maurya
Deepa Singh
Asha Bhagat
Om Gupta
Sukhdev Handa
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Application granted granted Critical
Publication of ATE399778T1 publication Critical patent/ATE399778T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT02714415T 2002-04-08 2002-04-08 Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon ATE399778T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000105 WO2003087093A1 (en) 2002-04-08 2002-04-08 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof

Publications (1)

Publication Number Publication Date
ATE399778T1 true ATE399778T1 (de) 2008-07-15

Family

ID=29227416

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02714415T ATE399778T1 (de) 2002-04-08 2002-04-08 Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon

Country Status (7)

Country Link
EP (1) EP1495019B1 (de)
JP (1) JP4309769B2 (de)
CN (1) CN1280290C (de)
AT (1) ATE399778T1 (de)
AU (1) AU2002246317A1 (de)
DE (1) DE60227421D1 (de)
WO (1) WO2003087093A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2363941T3 (es) 2003-03-14 2011-08-19 Astellas Pharma Inc. Derivados de c-glucósido para el tratamiento de diabetes.
EP1679965A4 (de) 2003-08-01 2009-05-27 Janssen Pharmaceutica Nv Substituierte anellierte heterocyclische c-glycoside
WO2005012242A2 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica Nv Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
TW200526678A (en) 2003-08-01 2005-08-16 Janssen Pharmaceutica Nv Substituted indole-O-glucosides
WO2005011592A2 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indazole-o-glucosides
BRPI0508259A (pt) * 2004-03-04 2007-07-31 Kissei Pharmaceutical derivado heterocìclico fundido, composição medicinal contendo o mesmo, e uso medicinal do mesmo
PL381247A1 (pl) * 2004-03-04 2007-05-14 Kissei Pharmaceutical Co., Ltd. Skondensowana pochodna heterocykliczna, zawierająca ją kompozycja lecznicza, oraz jej zastosowanie lecznicze
WO2008075736A1 (ja) 2006-12-21 2008-06-26 Astellas Pharma Inc. C-グリコシド誘導体の製造方法及びその合成中間体
TW201623321A (zh) 2014-05-13 2016-07-01 韓美藥品股份有限公司 雙環衍生物及包含其之藥學組成物
CN106674311B (zh) * 2016-12-27 2019-02-05 西安交通大学 一种苯并呋喃苷类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627611B2 (en) * 2000-02-02 2003-09-30 Kotobuki Pharmaceutical Co Ltd C-glycosides and preparation of thereof as antidiabetic agents

Also Published As

Publication number Publication date
AU2002246317A1 (en) 2003-10-27
WO2003087093A1 (en) 2003-10-23
CN1633432A (zh) 2005-06-29
JP4309769B2 (ja) 2009-08-05
JP2005528398A (ja) 2005-09-22
EP1495019B1 (de) 2008-07-02
DE60227421D1 (de) 2008-08-14
EP1495019A1 (de) 2005-01-12
CN1280290C (zh) 2006-10-18

Similar Documents

Publication Publication Date Title
WO2004037181A3 (en) Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
DK1506203T3 (da) Syntese af epothiloner, mellemprodukter deraf, analoger deraf og anvendelser deraf
DE60330015D1 (de) Aza-bicycloalkylether und deren verwendung als alpha7-nachr agonisten
DE60315323D1 (de) Piperidinderivate zur verwendung bei der behandlung von durch chemokins vermittelten leiden
DE60226764D1 (de) Substituierte heteroarylalkansäure und ihre verwendung als inhibitoren der aldose reductase
ATE534656T1 (de) Neue oligosaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE399778T1 (de) Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon
ATE246180T1 (de) Benzofuranon-derivate und verfahren zu ihrer herstellung
SE9804212D0 (sv) Compounds
NO20054787D0 (no) Indenderivater som farmasotiske midler
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
ATE454383T1 (de) Neue verbindungen, deren verwendung und herstellung
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
ATE214375T1 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
ATE308513T1 (de) Naphthamid-neurokinin antagonisten zur verwendung als medikamente
ATE365162T1 (de) Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
ATE358675T1 (de) Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol
AU2002212241A1 (en) Method for producing chiral compounds
ATE501158T1 (de) Neue 2-halogen-derivate von 5-o- desosaminylerythronolid a, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
EA200100156A3 (ru) Новые производные 6-сульфамоил-3-хинолилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции
DE60306122D1 (de) Pyridazinderivate, deren verwendung als heilmittel, und deren verfahren zu ihrer verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties